Results 181 to 190 of about 454,663 (343)

Implications of gut microbiota in hepatic and pancreatic diseases: Gut-liver-pancreas axis. [PDF]

World J Hepatol
Abdelwahab MM, Ghattas AS, Tawheed A.
europepmc   +1 more source

Therapeutic role of interleukin-1 receptor antagonist in pancreatic diseases: mendelian randomization study. [PDF]

Front Immunol, 2023
Yuan S, Miao Y, Ruan X, Chen J, Li X, Larsson SC.   +5 more
europepmc   +1 more source

Pancreatic Disease and Acute Intermittent Porphyria

, 1977
Camille Buffet, J C Chaput, D. Labayle F. Gayral, J P Etienne   +3 more
openalex   +1 more source

Engineered Plasmonic and Fluorescent Nanomaterials for Biosensing, Motion, Imaging, and Therapeutic Applications

Advanced Materials, EarlyView.
A schematic illustration of how noble metals can be used to create nanoparticles (NPs) or nanoclusters (NCs). Noble metal NPs, due to their plasmonic properties, enable photothermal therapy and surface‐enhanced Raman scattering (SERS). In contrast, NCs, which lack a plasmonic resonance band, exhibit fluorescence, making them ideal for bioimaging ...
David Esporrín‐Ubieto, Juan C. Fraire, Daniel Sánchez‐deAlcázar, Samuel Sánchez   +3 more
wiley   +1 more source

Obesity and Pancreatic Diseases: From Inflammation to Oncogenesis and the Impact of Weight Loss Interventions. [PDF]

Nutrients
Souto M, Cúrdia Gonçalves T, Cotter J.
europepmc   +1 more source

Impact of the COVID-19 Pandemic on the Management of Gallbladder, Biliary Tract, and Pancreatic Diseases. [PDF]

Cureus, 2023
Ilyas Khan A, Thomas C, O'Connor H, Dowker F, Horgan L, Khan MA.   +5 more
europepmc   +1 more source

Bioprinted Constructs in the Regulatory Landscape: Current State and Future Perspectives

Advanced Materials, EarlyView.
Bioprinting has rapidly emerged as a transformative technology in biomedical research, offering unprecedented potential to replicate complex tissues. Despite its promise, clinical translation remains limited due to regulatory hurdles. This review explores global regulatory frameworks, comparing approaches in the EU, U.S., China, and Australia, and ...
Francesca Perin, Liliang Ouyang, Khoon S. Lim, Antonella Motta, Devid Maniglio, Lorenzo Moroni, Carlos Mota   +6 more
wiley   +1 more source

Phospholipase D2: A biomarker implicated in various pancreatic diseases beyond acute pancreatitis. [PDF]

World J Gastroenterol
Tornel Avelar AI, Gerrard CN, Priego Parra BA.   +2 more
europepmc   +1 more source

Optimal glycated hemoglobin A1c value for prediabetes and diabetes in patients with pancreatic diseases. [PDF]

Front Endocrinol (Lausanne), 2023
Chen G, Zhang R, Tan C, Liu X, Yu L, Chen Y.   +5 more
europepmc   +1 more source

Diagnosis of Pancreatic Diseases by Scintigraphy

, 1974
Masatada TANABE, Toyosato TAMAI, Yoshio Hiraki, Kazuhiko Ehara, Hisao Takagi, Yoshio Haisa, Yasumasa KUMADA, Hiroshi Wakabayashi, Gonosuke Hashimoto   +8 more
openalex   +2 more sources